Data as of Q4 2025 (Dec 31, 2025)

Guardian Pharmacy Services, Inc.

(GRDN)

Financial Statements · SEC EDGAR XBRL

Revenue
$1.45B
+17.9%
Net Income
$49.2M
+144.7%
Gross Margin
20.2%
Op. Income
$72.7M
+215.5%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Cost of Revenues
Gross Profit
Operating Expenses & Income
Selling General & Admin
Operating Income
Non-Operating Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
Net Income
FY 2025
FY 2024
$1.45B
$1.23B
$1.45B
$1.23B
$1.16B
$984.0M
$292.7M
$244.4M
$220.0M
$307.3M
$72.7M
-$62.9M
$722K
-$3.6M
$73.4M
-$66.5M
$24.5M
$4.6M
$49.2M
-$110.0M